Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11795434
Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof
granted -
US 11786582
Human application of engineered chimeric antigen receptor (CAR) T-cells
granted -
US 11788141
MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
granted -
US 11781110
Induction of corneal endothelial cells
granted -
US 11760980
Induced pluripotent stem cells (IPSCS) and applications thereof
granted -
US 11759461
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 11730767
Methods, apparatuses and systems for instilling stem cells and pharmaceuticals into the human ventricular system
granted -
US 11723923
Methods of preparing T cells for T cell therapy
granted -
US 11723922
CXCR6-transduced T cells for targeted tumor therapy
granted -
US 11713446
Processes for generating TIL products enriched for tumor antigen-specific T-cells
granted -
US 11702630
In vitro methods of differentiating stem cells into neurons and neurons generated using the same
granted -
US 11702656
Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neurodegenerative diseases and disorders
granted -
US 11696929
Methods and systems for conserving highly expanded cells
granted -
US 11690919
Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells
granted -
US 11685775
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
granted -
US 11679130
Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11679131
Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11680244
Method for generating human dendritic cells for immunotherapy
granted -
US 11679128
Methods of producing enriched populations of tumor reactive T cells from peripheral blood
granted -
US 11672831
Use of adipose tissue-derived stromal stem cells in treating fistula
granted -
US 11672832
Development of amnion-like tissue from human pluripotent stem cells
granted -
US 11666602
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
granted -
US 11666562
Ilaprazole for inhibiting the release of enveloped viruses from cells
granted -
US 11667890
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
granted